Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Resolution . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107759601A details high-purity Ruxolitinib synthesis. Offers cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.
Patent CN106008318B reveals advanced chiral dye synthesis for OLED. Discover cost reduction in electronic chemical manufacturing and high-purity supply solutions.
Patent CN101501000B details a novel purification process for Montelukast using chiral amine salts, offering high optical purity and cost reduction in pharmaceutical intermediate manufacturing without chromatography.
Patent CN110668958A reveals a high-purity synthesis route for (R)-3-aminobutanol, a key Dolutegravir intermediate, offering significant cost and supply chain advantages.
Patent CN103159633A reveals a scalable route for Tapentadol intermediates, eliminating chiral columns and harsh demethylation for cost-effective manufacturing.
Novel synthesis process for chiral N-BOC-pyrrolidine-2-boric acid offers improved yield and purity. Reliable supply chain solution for pharmaceutical intermediate manufacturing needs.
Patent CN112500380A details a high-yield Ramelteon synthesis using NiCl2 reduction and S-Mandelic acid resolution, offering significant cost reduction and supply chain reliability.
Patent CN102050800A details a cost-effective chiral resolution method for antidepressant intermediates, replacing complex asymmetric synthesis with scalable salt formation.
Patent CN113087630A introduces a novel recycling method for (R)-(+)-alpha-phenylethylamine, ensuring high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN105061219A enables high-purity S-1-aminoindane via D-mandelic acid resolution. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel route from Itaconic Anhydride using chiral hydrogenation and lipase hydrolysis for high-purity Sacubitril intermediates. Cost-effective and scalable manufacturing solution.
Patent CN121318979A details a high-purity Poncirtinib Phosphate process. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel inclusion resolution method for high-purity Rabeprazole. Reduces costs and ensures supply chain stability for pharmaceutical intermediates.
Patent CN104628720A offers high purity moxifloxacin hydrochloride refining. Enhances supply chain reliability and cost reduction in pharmaceutical manufacturing.
Patent CN110563623A reveals a novel L-(+)-selenomethionine synthesis using selenium powder. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing.
Novel synthesis patent CN118666668A offers high purity above 99% and scalable purification for pharmaceutical intermediates supply chain stability and cost efficiency in global manufacturing.
Novel recovery method for L-camphorsulfonic acid resolving agent ensuring high purity and yield over 89 percent for cost-effective Clopidogrel manufacturing.
Novel reduction and resolution process for high-purity Pitavastatin Calcium. Enhances supply chain reliability and reduces manufacturing costs for global pharma partners.
Patent CN103435523B reveals a cost-effective route for Sitafloxacin intermediates ensuring supply chain stability and high purity for global pharmaceutical manufacturing partners.
Novel patent CN106188047B details high-yield synthesis of moxifloxacin intermediate. Offers cost reduction and supply chain reliability for pharmaceutical manufacturers seeking scalable solutions.